Your browser doesn't support javascript.
loading
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Shaw, Bronwen E; Logan, Brent R; Kiefer, Deidre M; Chitphakdithai, Pintip; Pedersen, Tanya L; Abdel-Azim, Hisham; Abidi, Muneer H; Akpek, Gorgun; Diaz, Miguel A; Artz, Andrew S; Dandoy, Christopher; Gajewski, James L; Hematti, Peiman; Kamble, Rammurti T; Kasow, Kimberley A; Lazarus, Hillard M; Liesveld, Jane L; Majhail, Navneet S; O'Donnell, Paul V; Olsson, Richard F; Savani, Bipin N; Schears, Raquel M; Stroncek, David F; Switzer, Galen E; Williams, Eric P; Wingard, John R; Wirk, Baldeep M; Confer, Dennis L; Pulsipher, Michael A.
Affiliation
  • Shaw BE; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. Electronic address: bshaw@doctors.org.uk.
  • Logan BR; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
  • Kiefer DM; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
  • Chitphakdithai P; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
  • Pedersen TL; Allina Health, Minneapolis, MN.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA.
  • Abidi MH; Division of BMT, Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI.
  • Akpek G; Stem Cell Transplantation and Cellular Therapy Program, Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Artz AS; Section of Hematology/Oncology, University of Chicago, Chicago, IL.
  • Dandoy C; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Gajewski JL; Oregon Health and Science University, Portland, OR.
  • Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, University of Wisconsin Hospital and Clinics, Madison, WI.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX.
  • Kasow KA; Division of Hematology-Oncology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
  • Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH.
  • Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, NY.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • O'Donnell PV; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Olsson RF; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Schears RM; Mayo Clinic Rochester, Rochester, MN.
  • Stroncek DF; Department of Transfusion Medicine, Clinical Center-NIH, Bethesda, MD.
  • Switzer GE; University of Pittsburgh, Pittsburgh, PA.
  • Williams EP; BeTheMatch/National Marrow Donor Program, Minneapolis, MN.
  • Wingard JR; Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL.
  • Wirk BM; Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA.
  • Confer DL; BeTheMatch/National Marrow Donor Program, Minneapolis, MN.
  • Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital of Los Angeles, USC Keck School of Medicine, Los Angeles, CA.
Biol Blood Marrow Transplant ; 21(10): 1830-8, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26116089
Previous studies have shown that risks of collection-related pain and symptoms are associated with sex, body mass index, and age in unrelated donors undergoing collection at National Marrow Donor Program centers. We hypothesized that other important factors (race, socioeconomic status [SES], and number of procedures at the collection center) might affect symptoms in donors. We assessed outcomes in 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors collected between 2004 and 2009. Pain/symptoms are reported as maximum levels over mobilization and collection (PBSC) or within 2 days of collection (BM) and at 1 week after collection. For PBSC donors, race and center volumes were not associated with differences in pain/symptoms at any time. PBSC donors with high SES levels reported higher maximum symptom levels 1 week after donation (P = .017). For BM donors, black males reported significantly higher levels of pain (OR, 1.90; CI, 1.14 to 3.19; P = .015). No differences were noted by SES group. BM donors from low-volume centers reported more toxicity (OR, 2.09; CI, 1.26 to 3.46; P = .006). In conclusion, race and SES have a minimal effect on donation-associated symptoms. However, donors from centers performing ≤ 1 BM collection every 2 months have more symptoms after BM donation. Approaches should be developed by registries and low-volume centers to address this issue.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Social Class / Tissue Donors / Bone Marrow Transplantation / Tissue and Organ Harvesting / Peripheral Blood Stem Cell Transplantation / Racial Groups / Hospitals, High-Volume / Hospitals, Low-Volume Type of study: Etiology_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Social Class / Tissue Donors / Bone Marrow Transplantation / Tissue and Organ Harvesting / Peripheral Blood Stem Cell Transplantation / Racial Groups / Hospitals, High-Volume / Hospitals, Low-Volume Type of study: Etiology_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2015 Type: Article